0001104659-21-093195.txt : 20210716 0001104659-21-093195.hdr.sgml : 20210716 20210716210308 ACCESSION NUMBER: 0001104659-21-093195 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210715 FILED AS OF DATE: 20210716 DATE AS OF CHANGE: 20210716 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Love Colin CENTRAL INDEX KEY: 0001376493 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38596 FILM NUMBER: 211096652 MAIL ADDRESS: STREET 1: C/O REPLIMUNE GROUP, INC. STREET 2: 18 COMMERCE WAY CITY: WOBURN STATE: MA ZIP: 10801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Replimune Group, Inc. CENTRAL INDEX KEY: 0001737953 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 822082553 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: (781) 222-9600 MAIL ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 4 1 tm2122438-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-07-15 0 0001737953 Replimune Group, Inc. REPL 0001376493 Love Colin C/O REPLIMUNE GROUP, INC. 500 UNICORN PARK WOBURN MA 01801 0 1 0 0 Chief Operating Officer Common Stock 2021-07-15 4 S 0 30000 32.02 D 835809 D The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. Following the sales reported on this Form 4, the reporting person continues to beneficially own 835,809 shares of the Issuer's common stock. The reporting person also holds options to acquire 503,578 shares of the Issuer's common stock, 299,790 of which are exercisable as of the date hereof. /s/ Jean Franchi, attorney-in-fact 2021-07-16